Skip to main content

Table 2 Base-case cost estimates ($, year 2013 values) and utilities

From: Cost-effectiveness analysis of adjuvant chemotherapies in patients presenting with gastric cancer after D2 gastrectomy

Parameter Median Range Description and reference
Costs    
Cost of capecitabine per 500 mg 6.6 Fixed Local charge
Cost of S-1 per 20 mg 9.6 7.9 - 10.1 Local charge
Cost of oxaliplatin per 50 mg 88.9 77.3 - 464.5 Local charge
Cost of follow-up per unit 56.5 42.3 - 70.6 Calculation
Cost of tests per 6-weeks of adjuvant with S-1 197.8 15.9 - 317.5 [31]
Cost of salvage chemotherapy per 3-week cycle 2334.6 1429.3 - 3323.2 Calculation
Cost of palliative end-of-life care 1460.3 1055.3 - 2085.7 Calculation
Cost of supportive care per cycle 115.2 31.7 - 317.5 Calculation
Cost of ADR per 6-week period of adjuvant with S-1 42.3 7.9 - 79.4 [31]
Cost of ADR per 3-week cycle of adjuvant with XELOX strategy 68.9 15.9 - 158.7 [31]
Cost of hospitalization per 3-week cycle of adjuvant with XELOX strategy 373 238.1 - 793.7 [31]
Utilities    
Utility of disease-free survival 0.88 0.8 - 0.97 Measured
Utility of recurrent disease 0.42 0.28 - 0.63 Measured
  1. Key: “&” Values were measured by time trade-off (TTO).